For US residents only.

Financial Resources

ZYKADIA^® (ceritinib) tablets

< Back To Site

Prescribing Info including Patient Info

Patient Support Line 1-888-669-6682 M-F 8:30 AM-5:00 PM ET

Important Safety Information:

What is the most important information I should know about ZYKADIA?

ZYKADIA may cause serious side effects, such as:

Stomach and intestinal (gastrointestinal) problems ZYKADIA may cause stomach and inte...

Approved Use:

What is ZYKADIA?

ZYKADIA is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that:

Is caused by a defect in a gene called anaplastic lymphoma kinase (ALK) and has spread to other parts of the body

It is not known if ZYKADIA is safe and effective in children.

Support designed for patients and caregivers

Insurance and Medicare education to help you understand the insurance process
Financial assistance for eligible patients*
Patient Navigators who provided 1-on-1 support specific to your Novartis medicine(s)*
Information about independent organizations that can assist you with your day-to-day needs beyond medical care
Patient Support Counselors who are able to provide information in over 160 languages

*Varies by product

To learn more about what’s available, call 1-800-282-7630 or visit www.Patient.NovartisOncology.com/.